Let's focus on what we can do!

By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • T2 Biosystems to develop, commercialize diagnostic test for early Lyme disease – Seeking Alpha

T2 Biosystems to develop, commercialize diagnostic test for early Lyme disease – Seeking Alpha

Saturday, 15 October, 2022

T2 Biosystems to develop, commercialize diagnostic test for early Lyme disease – Seeking Alpha

T2 Biosystems (NASDAQ:TTOO) said on Thursday it had planned to complete development of, and commercialize, a diagnostic test to detect early Lyme disease.

The company expects to begin marketing and sales in the United States as a Laboratory Developed Test (LDT) in 2023.

Read more at: https://seekingalpha.com/news/3891117-t2-biosystems-to-develop-commercialize-diagnostic-test-for-early-lyme-disease

Categories :
  • Latest Headlines
  • Lyme disease
Socials :

Recent posts